Clinical trial
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow…
NCT00438958 · The Canadian Blood and Marrow Transplant Group, Other · Completed
Key facts
| NCT number | NCT00438958 |
|---|---|
| Title | Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases |
| Official title | A Randomized Multicentre Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation for Hematologic Malignancies |
| Lead sponsor | The Canadian Blood and Marrow Transplant Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Secondary Myelofibrosis |
| Intervention type | Biological, Procedure |
| Interventions | filgrastim, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation |
| Enrollment | 230 |
| Start date | Mar 1, 2007 |
| First posted | Feb 22, 2007 |
| Last update posted | Mar 5, 2014 |
| Countries | Australia, Canada, New Zealand, Saudi Arabia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: